Vaccarella S, Franceschi S, Bray F, Wild CP, Plummer M, Dal Maso L. Worldwide thyroid-Cancer epidemic? The increasing impact of overdiagnosis. N Engl J Med. 2016;375:614–7. https://doi.org/10.1056/NEJMp1604412.

Article  PubMed  Google Scholar 

Lim H, Devesa SS, Sosa JA, Check D, Kitahara CM. Trends in thyroid Cancer incidence and mortality in the United States, 1974–2013. JAMA. 2017;317:1338–48. https://doi.org/10.1001/jama.2017.2719.

Article  PubMed  PubMed Central  Google Scholar 

Tuttle RM, Alzahrani AS. Risk stratification in differentiated thyroid Cancer: from detection to final Follow-Up. J Clin Endocrinol Metab. 2019;104:4087–100. https://doi.org/10.1210/jc.2019-00177.

Article  PubMed  PubMed Central  Google Scholar 

Haugen BR, Alexander EK, Bible KC, Doherty GM, Mandel SJ, Nikiforov YE, Pacini F, Randolph GW, Sawka AM, Schlumberger M, Schuff KG, Sherman SI, Sosa JA, Steward DL, Tuttle RM, Wartofsky L. 2015 American Thyroid Association Management Guidelines for adult patients with thyroid nodules and differentiated thyroid Cancer: the American Thyroid Association Guidelines Task Force on thyroid nodules and differentiated thyroid Cancer. Thyroid. 2016;26:1–133.

Article  PubMed Central  Google Scholar 

Tuttle RM, Zhang L, Shaha A. A clinical framework to facilitate selection of patients with differentiated thyroid cancer for active surveillance or less aggressive initial surgical management. Expert Rev Endocrinol Metab. 2018;13:77–85. https://doi.org/10.1080/17446651.2018.1449641.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Bojoga A, Koot A, Bonenkamp J, de Wilt J, IntHout J, Stalmeier P, Hermens R, Smit J, Ottevanger P, Netea-Maier R. The impact of the extent of Surgery on the long-term outcomes of patients with low-risk differentiated non-medullary thyroid Cancer: a systematic Meta-analysis. J Clin Med. 2020;9:2316. https://doi.org/10.3390/jcm9072316.

Article  PubMed  PubMed Central  Google Scholar 

Matsuura D, Yuan A, Harris V, Shaha AR, Tuttle RM, Patel SG, Shah JP, Ganly I. Surgical Management of Low-/Intermediate-Risk Node negative thyroid Cancer: a single-Institution Study using propensity matching analysis to compare thyroid lobectomy and total thyroidectomy. Thyroid. 2022;32:28–36. https://doi.org/10.1089/thy.2021.0356.

Article  CAS  PubMed  PubMed Central  Google Scholar 

Jerkovich F, Cavallo A, Fassi J, Guerra J, Zund S, Neguerela MC, Faure E, Bielski L, Reyes A, Brenta G, Pitoia F. Lobectomy for low and low-intermediate-risk of recurrence differentiated thyroid cancer: multicentric study from Argentina. In: Latin American Thyroid Congress; April 20 to 23, 2023; Curitiba, Brazil:117023.

Hauch A, Al-Qurayshi Z, Randolph G, Kandil E. Total thyroidectomy is associated with increased risk of Complications for low- and high-volume surgeons. Ann Surg Oncol. 2014;21:3844–52. https://doi.org/10.1245/s10434-014-3846-8.

Article  PubMed  Google Scholar 

Smulever A, Pitoia F. High rate incidence of post-surgical adverse events in patients with low-risk papillary thyroid cancer who did not accept active surveillance. Endocrine. 2020;69:587–95. https://doi.org/10.1007/s12020-020-02310-8.

Article  CAS  PubMed  Google Scholar 

Mirghani H, Altedlawi Albalawi. IA 2nd. The Ongoing Debate regarding Completion Thyroidectomy Versus primary thyroid Surgery for low and intermediate differentiated thyroid carcinoma: a Meta-analysis. Cureus. 2020;12:e12033. https://doi.org/10.7759/cureus.12033.

Article  PubMed  PubMed Central  Google Scholar 

Li Z, Qiu Y, Fei Y, Xing Z, Zhu J, Su A. Prevalence of and risk factors for hypothyroidism after hemithyroidectomy: a systematic review and meta-analysis. Endocrine. 2020;70:243–55. https://doi.org/10.1007/s12020-020-02410-5.

Article  CAS  PubMed  Google Scholar 

Lee SJ, Song CM, Ji YB, Choi YY, Sohn YS, Park JH, Kim DS, Tae K. Risk factors for hypothyroidism and thyroid hormone replacement after hemithyroidectomy in papillary thyroid carcinoma. Langenbecks Arch Surg. 2021;406:1223–31. https://doi.org/10.1007/s00423-021-02189-7.

Article  PubMed  Google Scholar 

Dou Y, Chen Y, Hu D, Su X. The recovery of thyroid function in low-risk papillary thyroid Cancer after Lobectomy: a 3-Year Follow-Up study. Front Endocrinol (Lausanne). 2021;11:619841. https://doi.org/10.3389/fendo.2020.619841.

Article  PubMed  Google Scholar 

Cox C, Bosley M, Southerland LB, Ahmadi S, Perkins J, Roman S, Sosa JA, Carneiro-Pla D. Lobectomy for treatment of differentiated thyroid cancer: can patients avoid postoperative thyroid hormone supplementation and be compliant with the American Thyroid Association guidelines? Surgery. 2018;163:75–80. https://doi.org/10.1016/j.surg.2017.04.039.

Article  PubMed  Google Scholar 

Lee MC, Kim MJ, Choi HS, Cho SW, Lee GH, Park YJ, Park DJ. Postoperative thyroid-stimulating hormone levels did not affect recurrence after thyroid lobectomy in patients with papillary thyroid Cancer. Endocrinol Metab (Seoul). 2019;34:150–7. 103803/EnM.2019.34.2.150.

Article  CAS  PubMed  Google Scholar 

Xu S, Huang Y, Huang H, Zhang X, Qian J, Wang X, Xu Z, Liu S, Liu J. Optimal serum Thyrotropin Level for patients with papillary thyroid Carcinoma after Lobectomy. Thyroid. 2022;32:138–44. https://doi.org/10.1089/thy.2021.0404.

Article  CAS  PubMed  Google Scholar 

Lang BH, Wong CKH. Lobectomy is a more cost-effective option than total thyroidectomy for 1 to 4 cm papillary thyroid carcinoma that do not possess clinically recognizable high-risk features. Ann Surg Oncol. 2016;23:3641–52. https://doi.org/10.1245/s10434-016-5280-6.

Article  PubMed  Google Scholar 

Pitoia F, Smulever A. Vigilancia Activa Encubierta Y Los costos de la ausencia de implementación de la cirugía diferida en Argentina. Rev Argent Endocrinol Metab. 2020;57(3):1–10.

Google Scholar 

Landry V, Siciliani E, Henry M, Payne RJ. Health-Related Quality of Life following total thyroidectomy and lobectomy for differentiated thyroid carcinoma: a systematic review. Curr Oncol. 2022;29:4386–422. https://doi.org/10.3390/curroncol29070350.

Article  PubMed  PubMed Central  Google Scholar 

Singer S, Lincke T, Gamper E, Bhaskaran K, Schreiber S, Hinz A, Schulte T. Quality of life in patients with thyroid cancer compared with the general population. Thyroid. 2012;22:117–24. https://doi.org/10.1089/thy.2011.0139.

Article  PubMed  Google Scholar 

NCCN clinical practice guidelines in oncology (NCCN Guidelines). : thyroid carcinoma—version 2.2017. https://www.nccn.org/professionals/physician_gls/pdf/thyroid.pdf. Accessed April 25, 2018.

Cooper DS, Doherty GM, Haugen BR, Kloss RT, Lee SL, Mandel SJ, Mazzaferri EL, Mclver B, Pacini F, Schlumberger M, Sherman SI, Steward DL, Tuttle RM. Revised American Thyroid Association management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2009;19:1167–214. https://doi.org/10.1089/thy.2009.0110.

Article  PubMed  Google Scholar 

Cooper DS, Doherty GM, Haugen BR, Kloss RT, Lee SL, Mandel SJ, Mazzaferri EL, Mclver B, Sherman SI, Tuttle RM, American Thryoid Association Guidelines Taskforce. Management guidelines for patients with thyroid nodules and differentiated thyroid cancer. Thyroid. 2006;16:109–42. https://doi.org/10.1089/thy.2006.16.109.

Article  PubMed  Google Scholar 

Bilimoria KY, Bentrem DJ, Ko CY, Stewart AK, Winchester DP, Talamonti MS, Sturgeon C. Extent of surgery affects survival for papillary thyroid cancer. Ann Surg. 2007; 246:375–381. doi: 20.1097/SLA.0b013e31814697d9.

In H, Bilimoria KY, Stewart AK, Wroblewsli KE, Posner MC, Talamonti MS, Winchester DP. Cancer recurrence: an important but missing variable in national cancer registries. Ann Surg Oncol. 2014;21:1520–9. https://doi.org/10.1245/s10434-014-3516.

Article  PubMed  Google Scholar 

Grant CS, Hay ID, Gough IR, Bergstralh EJ, Goellner JR, McConahey WM. Local recurrence in papillary thyroid carcinoma: is extent of surgical resection important? Surgery. 1988;104:954–62.

CAS  PubMed  Google Scholar 

Hay ID, Grant CS, Bergstralh EJ, Thompson GB, van Heerden JA, Goellner JR. Unilateral total lobectomy: is it sufficient surgical treatment for patients with AMES low-risk papillary thyroid carcinoma? Surgery. 1998;124:958–64.

Article  CAS  Google Scholar 

Mazzaferri EL, Kloos RT. Clinical review 128: current approaches to primary therapy for papillary and follicular thyroid cancer. J Clin Endocrinol Metab. 2001;86:1447–63. https://doi.org/10.1210/jcem.86.4.7407.

Article  CAS  PubMed  Google Scholar 

Adam MA, Pura J, Gu L, Dinan MA, Tyler DS, Reed SD, Scheri R, Roman SA, Sosa JA. Extent of Surgery for papillary thyroid cancer is not associated with survival: an analysis of 61,775 patients. Ann Surg. 2014;260:601–5. https://doi.org/10.1097/SLA.0000000000000925. discussion 605-7.

Article  PubMed  Google Scholar 

Nixon IJ, Palmer FL, Whitcher MM, Shaha AR, Shah JP, Patel SG, Ganly I. Thyroid isthmusectomy for well- differentiated thyroid cancer. Ann Surg Oncol. 2011;18:767–70. https://doi.org/10.1245/s10434-010-1358-8.

Article  PubMed  Google Scholar 

Haigh PI, Urbach DR, Rotstein LE. Extent of thyroidectomy is not a major determinant of survival in low- or high-risk papillary thyroid cancer. Ann Surg Oncol. 2005;12:81–9. https://doi.org/10.1007/s1043-004-1165-1.

Article  PubMed  Google Scholar 

Barney BM, Hitchcock YJ, Sharma P, Shrieve DC, Tward JD. Overall and cause- specific survival for patients undergoing lobectomy, near-total, or total thyroidectomy for differentiated thyroid cancer. Head Neck. 2011;33:645–9. https://doi.org/10.1002/hed.21504.

Article  PubMed  Google Scholar 

Mendelsohn AH, Elashoff DA, Abemayor E, St John MA. Surgery for papillary thyroid carcinoma: is lobectomy enough? Arch Otolaryngol Head Neck Surg. 2010;136:1055–61. https://doi.org/10.1001/archoto.2010.181.

Article  PubMed  Google Scholar 

Matsuzu K, Sugino K, Masudo K, Nagahama M, Kitagawa W, Shibuya H, Ohkuwa K, Uruno T, Suzuki A, Magoshi S, Akaishi J, Masaki C, Kawano M, Suganuma N, Rino Y, Masuda m, Kameyama K, Takami H, Ito K. Thyroid lobectomy for papillary thyroid cancer: long-term follow-up study of 1,088 cases. World J Surg. 2014;38:68–79. https://doi.org/10.1007/s00268-013-2224-1.

Article  PubMed  Google Scholar 

Hay ID, Bergstralh EJ, Goellner JR, Ebersold JR, Grant CS. Predicting outcome in papillary thyroid carcinoma: development of a reliable prognostic scoring system in a cohort of 1779 patients surgically treated at one institution during 1940 through 1989. Surgery.1993; 114:1050-5; discussion 1057-8.

Hay ID, Thompson GB, Grant CS, Bergstralh EJ, Dvorak CE, Gorman CA, Maurer MS, McIver B, Mullan BP, Oberg AL, Powell CC, van Heerden JA, Goellner JR. Papillary thyroid carcinoma managed at the Mayo Clinic during six decades (1940–1999): temporal trends in initial therapy and long-term outcome in 2444 consecutively treated patients. World J Surg. 2002;26:879–85. https://doi.org/10.1007/s00268-002-6612.

Article